azathioprine has been researched along with Substance-Related Disorders in 6 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Age of onset, surgical past history of Crohn's disease, colonic or ileal involvement, or Harvey-Bradshaw score were not different between groups." | 1.30 | Anal lesions: any significant prognosis in Crohn's disease? ( Bretagne, JF; Gosselin, M; Juguet, F; Mary, JY; Mortaji, A; Siproudhis, L, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lémann, M | 1 |
| Mary, JY | 2 |
| Duclos, B | 1 |
| Veyrac, M | 1 |
| Dupas, JL | 1 |
| Delchier, JC | 1 |
| Laharie, D | 1 |
| Moreau, J | 1 |
| Cadiot, G | 1 |
| Picon, L | 1 |
| Bourreille, A | 1 |
| Sobahni, I | 1 |
| Colombel, JF | 1 |
| Saadeh, C | 1 |
| Urban, RS | 1 |
| Siproudhis, L | 1 |
| Mortaji, A | 1 |
| Juguet, F | 1 |
| Bretagne, JF | 1 |
| Gosselin, M | 1 |
| Kater, L | 1 |
| Borst-Eilers, E | 1 |
| McGinn, JT | 1 |
| McGinn, TG | 1 |
| Cherubin, CE | 1 |
| Hoffman, RS | 1 |
| Williams, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial Investigating Tailored Treatment With Infliximab for Active Luminal Crohn's Disease[NCT01442025] | Phase 4 | 121 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for azathioprine and Substance-Related Disorders
| Article | Year |
|---|---|
[Virus hepatitis B (serum hepatitis) I. Clinical data and epidemiology].
Topics: Adrenal Cortex Hormones; Antigen-Antibody Complex; Antigens, Viral; Azathioprine; Carrier State; Cro | 1975 |
1 trial available for azathioprine and Substance-Related Disorders
| Article | Year |
|---|---|
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Double-B | 2006 |
4 other studies available for azathioprine and Substance-Related Disorders
| Article | Year |
|---|---|
Azathioprine in the treatment of chronic refractory steroid-dependent asthma.
Topics: Adult; Asthma; Azathioprine; Chronic Disease; Humans; Male; Prednisone; Substance-Related Disorders | 1993 |
Anal lesions: any significant prognosis in Crohn's disease?
Topics: Adolescent; Adult; Aged; Anus Diseases; Azathioprine; Crohn Disease; Female; Fissure in Ano; Humans; | 1997 |
Nephrotic syndrome in drug addicts.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Male; Nephrotic Syndrome; Prednisone; Prognos | 1974 |
Chronic hepatitis.
Topics: Adult; Aged; Antibody Formation; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Protein | 1968 |